)
In-Licensing for Australia and New Zealand
CSL Seqirus In-Licensing
CSL Seqirus has extensive experience in commercialising pharmaceutical and vaccine products for international partners in Australia and New Zealand. We offer a flexible partnering approach, with an ability to tailor licensing arrangements to meet the needs of our partners. We have a proven track record across a range of therapeutic areas and channels, including GP, specialist and hospital.
Our multi-award winning sales and marketing teams are recognised as leaders within the pharmaceutical industry. With expertise in both private and reimbursed products, we can help you achieve your commercial goals.
Partnering Flexibility
Our team has a great ability to adapt to our partner’s needs.
.jpg?h=430&w=768&cropregion=0,2,1600,897&hash=84865D94997EF6820AA12F51FC102F14)
Performance Driven Teams
We have a robust track record building strong brands and achieving rapid market penetration in reimbursed and private markets in Australia and New Zealand.
Strategic Market Entry
CSL Seqirus has dedicated regulatory and health economics team to secure optimum labelling and pricing in Australia and New Zealand markets.
We Make it Our Own
We make a significant investment and focus our resources during all phases of your product’s lifecycle.